Mira Pharmaceuticals (MIRA) P/B (2023 - 2026)
Mira Pharmaceuticals (MIRA) P/B from Aug 3, 2023 to Jul 20, 2026. The TTM Mira Pharmaceuticals (MIRA) P/B is 4.13. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/B
Annual P/B change of Mira Pharmaceuticals (MIRA)
| Year | P/B | Change |
|---|---|---|
| 2026 | 4.13 | -32.16% |
| 2025 | 6.10 | -28.98% |
| 2024 | 8.58 | +348.98% |
| 2023 | 1.91 | N/A |
Comparison Mira Pharmaceuticals (MIRA) P/B with competitors
Mira Pharmaceuticals (MIRA) P/B is 4.13.
| Ticker | Name | P/B | Upside |
|---|---|---|---|
| AMRN | Amarin Corp | 0.68 | -83.46% |
| GRFS | Grifols SA | 0.79 | -80.89% |
| SNY | Sanofi | 1.27 | -69.29% |
| BIIB | Biogen Inc | 1.52 | -63.26% |
| PFE | Pfizer Inc | 1.55 | -62.56% |
| OGN | Organon & Company | 3.93 | -5.05% |
| GSK | GSK Plc | 4.37 | +5.74% |
| BMY | Bristol-Myers Squibb Company | 6.04 | +46.08% |
| AZN | Astrazeneca plc | 6.20 | +49.95% |
| MRK | Merck & Co Inc | 6.68 | +61.56% |
| GILD | Gilead Sciences Inc | 6.94 | +67.84% |
| NVO | Novo Nordisk | 7.07 | +70.99% |
| NVS | Novartis AG | 7.60 | +83.81% |
| JNJ | Johnson & Johnson | 7.64 | +84.77% |
| NSRX | Nasus Pharma Ltd | 12.90 | +211.99% |
| MDCX | MDCorp | 15.34 | +271.00% |
| AMGN | AMGEN Inc | 21.17 | +412.00% |
| SCLX | Scilex Holding Company | 28.85 | +597.74% |
| LLY | Lilly(Eli) & Company | 32.94 | +696.65% |
| ABBV | Abbvie Inc | 50.46 | +1120.38% |